In the last trading session, 16.44 million shares of the Ocean Biomedical Inc (NASDAQ:OCEA) were traded, and its beta was 1.41. Most recently the company’s share price was $0.09, and it changed around -$0.01 or -10.50% from the last close, which brings the market valuation of the company to $12.58M. OCEA currently trades at a discount to its 52-week high of $7.79, offering almost -8555.56% off that amount.

Ocean Biomedical Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended OCEA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Ocean Biomedical Inc is expected to report earnings per share of 0 for the current quarter.

Ocean Biomedical Inc (NASDAQ:OCEA) trade information

Instantly OCEA has showed a red trend with a performance of -10.50% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.1190 on recent trading dayincreased the stock’s daily price by 24.37%. The company’s shares are currently down -83.82% year-to-date, but still down -25.42% over the last five days. On the other hand, Ocean Biomedical Inc (NASDAQ:OCEA) is -52.77% down in the 30-day period.

OCEA Dividends

Ocean Biomedical Inc’s next quarterly earnings report is expected to be released in April.

Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 243.67 shares worth $21808.0, making up 0.17% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 156.2 shares worth around $13980.0, which represents about 0.11% of the total shares outstanding.